C. Light Raises Undisclosed Funding

C. Light, a Boston MA-based neurotech AI company, raised an undisclosed amount in funding.

Backers included the Alzheimer’s Drug Discovery Foundation (ADDF) through its Diagnostics Accelerator, a collaborative research initiative supported by Leonard A. Lauder, Bill Gates, the Dolby family, the Charles and Helen Schwab Foundation, Jeff Bezos and MacKenzie Scott among other leading philanthropists.

This new investment will fund a novel pilot study with the UCSF Memory and Aging Center to look at changes in fixational eye motion during the earliest stage of Alzheimer’s disease, generally known as mild cognitive impairment.

Led by Dr. Christy K. Sheehy, co-founder, C. Light is a neurotech and AI company that uses retinal eye-tracking to map neurodegeneration and therapeutic efficacy. The company will study retinal eye motion biomarkers to flag diagnosis, prognosis and monitoring of Alzheimer’s in tandem with new drug therapies. C. Light’s non-invasive technology enables clinicians to study and measure eye motion on the cellular scale, meaning eye motion as small as 1/100th the size of a human hair, helping physicians to monitor a patient’s disease and treat it more effectively.

The company recently completed its second and final seed round raising $500k including the ADDF investment, which brings their total seed funding to more than $3m. Second round seed funders included: ADDF, the Wisconsin River Business Angels, Abraham Investments, LLC and others.

FinSMEs

05/08/2021